Keypoint Intelligence Appoints Mark Boyt as Principal Analyst for Production Workflow Software

Keypoint Intelligence Appoints Mark Boyt as Principal Analyst for Production Workflow Software

FAIRFIELD, N.J., Feb. 26, 2025 /PRNewswire/ -- Keypoint Intelligence is pleased to announce that Mark Boyt has joined the company as Principal Analyst for Production Workflow Software. Boyt brings extensive experience in software marketing, business...

Corti's First AId Report: Burnout levels challenge healthcare professionals' ability to care for patients in Europe and the U.S.

Corti's First AId Report: Burnout levels challenge healthcare professionals' ability to care for patients in Europe and the U.S.

Artificial Intelligence could be a lifeline but unsuccessful trials, limited opportunities, and lack of experience is holding healthcare professionals back Europe lagging behind the U.S. in terms of acceptance and adoption of AI and differences...

Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S. Phase 1 trial is progressing smoothly, with no dose-limiting toxicity observed Phase 1 trial evaluating the combination of BH3120 and...

menu
menu